Twist Bioscience
TWST
262 hedge funds and large institutions have $3.25B invested in Twist Bioscience in 2024 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 88 increasing their positions, 79 reducing their positions, and 35 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
77% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 35
68% more call options, than puts
Call options by funds: $12.2M | Put options by funds: $7.25M
41% more capital invested
Capital invested by funds: $2.3B → $3.25B (+$947M)
11% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 79
11% more funds holding
Funds holding: 237 → 262 (+25)
3.03% less ownership
Funds ownership: 116.35% → 113.33% (-3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$58.2M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$39.4M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$35.5M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.4M |
| 5 |
FAM
Fred Alger Management
New York
|
+$23.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$58M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$33.2M |
| 3 |
State Street
Boston,
Massachusetts
|
-$32.5M |
| 4 |
JP Morgan Chase
New York
|
-$28.1M |
| 5 |
Bank of New York Mellon
New York
|
-$19M |
TWST Hedge Fund Activity: Q2 2024 in Review
262 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q2 2024, worth a combined $3.25B — up 41% from $2.3B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new TWST positions and 35 closed out — a net gain of 27 holders — while 88 added to existing stakes and 79 trimmed.
The largest buyer was Artisan Partners, adding an estimated $58.2M. The largest seller was Millennium Management, cutting an estimated $58M.
- 262 institutional investors held Twist Bioscience (TWST) as of Q2 2024, up from 237 in Q1 2024.
- Funds reported $3.25B of Twist Bioscience stock for Q2 2024, up 41% quarter-over-quarter.
- 62 funds opened new Twist Bioscience positions in Q2 2024 and 35 closed out, a net change of +27 holders.
- The largest Twist Bioscience buyer in Q2 2024 was Artisan Partners, an estimated $58.2M added.
- The largest Twist Bioscience seller in Q2 2024 was Millennium Management, an estimated $58M sold.
Based on aggregated 13F filings for Q2 2024.